Check out this week's QuadCast where we highlight the pros and cons of dose de-escalated RT for resected HPV+ oropharynx cancer, another trial showing that SBRT for oligometastatic prostate cancer improves outcomes, a model for predicting brain radiation necrosis with SRS, and more.
Check out this week's QuadCast where we highlight the pros and cons of dose de-escalated RT for resected HPV+ oropharynx cancer, another trial showing that SBRT for oligometastatic prostate cancer improves outcomes, a model for predicting brain radiation necrosis with SRS, and more.